Koninklijke Philips N.V. NY Reg (PHG) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $26.74, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7).
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes... Read more
Hold if already holding. Not a fresh buy at $26.74, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7). Chart setup: Death cross but MACD improving, RSI 64. Mixed signals. Hold existing position. Score 5.6/10, moderate confidence.
Passes 6/7 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity 69d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent Developments — Koninklijke Philips N.V. NY Reg
Latest news
- Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says S - GuruFocus — GuruFocus negative
- Philips (PHG) Achieves FDA Clearance for Advanced Spectral CT Sy - GuruFocus — GuruFocus positive
- What shapes market opinion on Koninklijke (PHG) stock | Koninklijke posts 4% EPS beat vs Street estimates - Sector Outpe — Newser positive
- Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating 22.82% Potential Upside in the Healthcare Sector - DirectorsTa — DirectorsTalk Interviews positive
- Koninklijke Philips NV (PHG) Shares Surge 3.7% -- What GF Score of 79 Tells Investors - GuruFocus — GuruFocus positive
Generated 2026-05-20T21:56:22Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $26.74, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7). Chart setup: Death cross but MACD improving, RSI 64. Mixed signals. Hold existing position. Target $29.18 (+9.1%), stop $25.62 (−4.4%), A.R:R 1.0:1. Score 5.6/10, moderate confidence.
Take-profit target: $29.18 (+9.1% upside). Target $29.18 (+9.1%), stop $25.62 (−4.4%), A.R:R 1.0:1. Stop-loss: $25.62.
Thin upside margin: 9.1%; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.7).
Koninklijke Philips N.V. NY Reg trades at a P/E of 22.5 (forward 12.7). TrendMatrix value score: 7.4/10. Verdict: Hold.
30 analysts cover PHG with a consensus score of 3.8/5. Average price target: $34.
What does Koninklijke Philips N.V. NY Reg do?Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and...
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.